Return On Equity in % of ReShape Lifesciences Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ReShape Lifesciences Inc. quarterly/annual Return On Equity history and growth rate from Q3 2019 to Q3 2025.
  • ReShape Lifesciences Inc. Return On Equity for the quarter ending September 30, 2025 was 488 %, a 315% increase year-over-year.
  • ReShape Lifesciences Inc. annual Return On Equity for 2024 was 152 %.
  • ReShape Lifesciences Inc. annual Return On Equity for 2020 was -300 %, a 61% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

ReShape Lifesciences Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 488 +370 +315% Jul 1, 2025 Sep 30, 2025
Q2 2025 99.1 Apr 1, 2025 Jun 30, 2025
Q1 2025 80.9 Jan 1, 2025 Mar 31, 2025
Q4 2024 152 Oct 1, 2024 Dec 31, 2024
Q3 2024 118 Jul 1, 2024 Sep 30, 2024
Q1 2021 -305 -156 -104% Jan 1, 2021 Mar 31, 2021
Q4 2020 -300 -114 -61% Oct 1, 2020 Dec 31, 2020
Q3 2020 -189 +39.5 +17.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -129 Apr 1, 2020 Jun 30, 2020
Q1 2020 -149 Jan 1, 2020 Mar 31, 2020
Q4 2019 -186 Oct 1, 2019 Dec 31, 2019
Q3 2019 -229 Jul 1, 2019 Sep 30, 2019

ReShape Lifesciences Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 152 Jan 1, 2024 Dec 31, 2024
2020 -300 -114 -61% Jan 1, 2020 Dec 31, 2020
2019 -186 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.